Your safety

Patient Safety and Risk Management
Stragen’s activities as a pharmaceutical company are carried out within a regulated framework at every stage of a drug’s lifecycle, while adhering to latest regulatory requirements and quality standards.
In terms of safety, our medications comply with European regulations. All of our medications are serialized and equipped with a tamper-evident system on each box. Our pharmacovigilance system continously monitor the benefit-risk balance of our medications meeting national and European regulatory requirements.
Certifications and licenses : GDP-certificate and wholesaler licence, Fimea
Pharmacovigilance
For all adverse event suspicion or a security issue concerning our products, please contact Finland’s affiliate:
-
By phone :+358 40 140 8856
-
Email: info@stragen.fi
Or our global pharmacovigilance department
-
By phone: +33 (0)4 78 42 95 26
- By email: pharmacovigilance@stragen.fr
Pharmacovigilance is vital in guarenteeing the safety of medical products. Reportings are essential to ensure a continuous monitoring and in improving the safety of medications. Please feel free to contact Stragen Finland or our pharmacovigilance team if you have any concerns or questions.